The National Medical Products Administration in China has approved pembrolizumab for use in combination with platinum and fluoropyrimidine-based chemotherapy for the frontline treatment of patients.
Gina Mauro
Advertisement
Editorial Director, OncLive
Gina Mauro is your lead editorial contact for OncLive. She joined the company in 2015 and has held various positions on OncLive; she is also the on-air correspondent for OncLive News Network: On Location. Prior to joining MJH Life Sciences, she worked at Gannett as a full-time reporter with the Asbury Park Press. Email: gmauro@onclive.com
Articles by Gina Mauro
Advertisement
Latest Updated Articles
Pembrolizumab Approved in China for Frontline Advanced Esophageal CancerPublished: September 8th 2021 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
Q&A: The Initiative Bringing Clinical Pharmacy Care to Underserved Patients’ Homes
2
Pharmacists Reimagine the Future of Pharmacy
3
Investigators Link Maternal Distress With Neurodevelopmental Delay Among Children
4
Pharmacists Discuss Innovation Strategies at NCPA 2025
5
